Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction.  Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications.   The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.  

Biotechnology

Health Care

Therini Bio, Inc.

Therini Bio, Inc.'s headquarters in San Francisco, CA, United States

Katerina Akassoglou

This department provides strategic guidance and oversight through board member engagement.

Board Oversight

This department manages clinical trial operations, ensuring compliance and efficiency in clinical studies.

Clinical Operations

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department focuses on overseeing and coordinating program initiatives and operational strategies to ensure alignment with organizational objectives.

Program Strategy

This department focuses on advancing medical knowledge and innovations in the field of ophthalmology.

Therini Bio, Inc.

Org chart

Teams

Board Oversight

Clinical Operations

Executive Leadership

Program Strategy

Research and Development

Offices

Therini Bio, Inc.

Org chart

Teams

Board Oversight

Clinical Operations

Executive Leadership

Program Strategy

Research and Development

Offices

Related companies